Literature DB >> 30175824

Active targeted drug delivery of MMP-2 sensitive polymeric nanoparticles.

Jie Pan1, Pei-Jiao Li, Yi Wang, Lu Chang, Dong Wan, Hao Wang.   

Abstract

Novel matrix metalloproteinase 2 (MMP2)-sensitive nanoparticles (NPs) are developed with copolymers of TPGS3350-pp-PLGA and TPGS-folate to overcome some drawbacks of traditional anticancer formulations in drug delivery, such as short circulation time in blood, small drug accumulation at the tumor site, low intracellular uptake, etc.

Entities:  

Year:  2018        PMID： 30175824     DOI： 10.1039/c8cc05504a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

Review 1.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

2.  The Effect of MMP-2 Inhibitor 1 on Osteogenesis and Angiogenesis During Bone Regeneration.

Authors:  Liangjun Jiang; Kunkun Sheng; Cong Wang; Deting Xue; Zhijun Pan
Journal:  Front Cell Dev Biol       Date:  2021-01-22

3.  Intelligent Drug Delivery by Peptide-Based Dual-Function Micelles.

Authors:  Dong Wan; Yujun Liu; Xinhao Guo; Jianxin Zhang; Jie Pan
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

4.  Intracellular and extracellular enzymatic responsive micelle for intelligent therapy of cancer.

Authors:  Dong Wan; Qinan Zhu; Jianxin Zhang; Xi Chen; Fangzhou Li; Yi Liu; Jie Pan
Journal:  Nano Res       Date:  2022-10-14       Impact factor: 10.269
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.